Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Petrilli AM, Garcia J, Bott M, Klingeman Plati S, Dinh CT, Bracho OR, Yan D, Zou B, Mittal R, Telischi FF, Liu XZ, Chang LS, Welling DB, Copik AJ, Fernández-Valle C.
Petrilli AM, et al.
Oncotarget. 2017 May 9;8(19):31666-31681. doi: 10.18632/oncotarget.15912.
Oncotarget. 2017.
PMID: 28427224
Free PMC article.